Take Solutions Ltd Share Price – NSE /  BSE

Healthcare, Small Cap

Net profit of Take Solutions reported to Rs 4.36 crore in the quarter ended March 2026 as against net loss of Rs 4.88 crore during the previous quarter ended March 2025. Sales reported to Rs 54.19 crore in the quarter ended March 2026. There were no Sales reported during the previous quarter ended March 2025.

For the full year,net profit declined 71.04% to Rs 10.85 crore in the year ended March 2026 as against Rs 37.47 crore during the previous year ended March 2025. Sales reported to Rs 54.19 crore in the year ended March 2026. There were no Sales reported during the previous year ended March 2025.

Powered by Capital Market - Live News

Take Solutions will hold a meeting of the Board of Directors of the Company on 20 May 2026.

The company plans to build a portfolio of science-backed nutraceuticals, biohacking products and digital wellness solutions targeting India?s growing health-conscious consumer base. The strategy combines product innovation with technology-enabled platforms aimed at improving metabolic health, sleep, cognition and biological aging.

Take Solutions said it will leverage its existing capabilities in clinical research, life sciences and regulatory processes to develop scalable and clinically credible offerings in the segment.

The move comes amid strong growth in the global longevity market, which is projected to expand from $27.61 billion in 2025 to $67.03 billion by 2035. In India, rising awareness around preventive healthcare and lifestyle diseases is driving demand for anti-aging products and services.

The company aims to build a diversified revenue stream across consumer health products, services and digital platforms as it taps into a market characterized by repeat consumption and improving margins.

Take Solutions operates as a technology-driven healthcare solutions provider with a focus on life sciences and supply chain industries.

On a consolidated basis, Take Solutions? net profit plunged 97.67% YoY to Rs 1.11 crore in Q3 December 2025 from Rs 47.68 crore in Q3 December 2024. The company reported no sales in both the current and corresponding previous quarter.

Take Solutions announced the launch of its Innovation Fund with an initial corpus commitment of Rs. 5 crore. The fund is aimed at identifying, investing in, and scaling high-potential startups operating at the convergence of Artificial Intelligence (AI), deep technology, and the rapidly expanding health and wellness sector.

The initiative underscores Take Solutions' strategic pivot towards enabling next-generation, technology led business models while creating long-term value for stakeholders. The Innovation Fund will focus on early- and growth-stage companies that are leveraging data, AI, and scientific innovation to transform healthcare delivery, diagnostics, and human health outcomes.